- Home
- NTRB vs VNRX Comparison
NTRB vs VNRX Comparison
Compare NTRB & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- VNRX
- Stock Information
- Founded
- NTRB 2016
- VNRX N/A
- Country
- NTRB United States
- VNRX United States
- Employees
- NTRB N/A
- VNRX N/A
- Industry
- NTRB Industrial Specialties
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NTRB Health Care
- VNRX Health Care
- Exchange
- NTRB Nasdaq
- VNRX Nasdaq
- Market Cap
- NTRB 59.1M
- VNRX 52.4M
- IPO Year
- NTRB N/A
- VNRX N/A
- Fundamental
- Price
- NTRB $7.75
- VNRX $0.51
- Analyst Decision
- NTRB Buy
- VNRX Strong Buy
- Analyst Count
- NTRB 1
- VNRX 4
- Target Price
- NTRB $13.00
- VNRX $4.17
- AVG Volume (30 Days)
- NTRB 28.3K
- VNRX 263.7K
- Earning Date
- NTRB 05-30-2025
- VNRX 05-15-2025
- Dividend Yield
- NTRB N/A
- VNRX N/A
- EPS Growth
- NTRB N/A
- VNRX N/A
- EPS
- NTRB N/A
- VNRX N/A
- Revenue
- NTRB $2,398,437.00
- VNRX $1,308,361.00
- Revenue This Year
- NTRB $571.50
- VNRX $563.72
- Revenue Next Year
- NTRB $577.37
- VNRX $160.43
- P/E Ratio
- NTRB N/A
- VNRX N/A
- Revenue Growth
- NTRB 18.92
- VNRX 64.16
- 52 Week Low
- NTRB $3.72
- VNRX $0.40
- 52 Week High
- NTRB $11.78
- VNRX $0.90
- Technical
- Relative Strength Index (RSI)
- NTRB 72.87
- VNRX 54.00
- Support Level
- NTRB $6.03
- VNRX $0.40
- Resistance Level
- NTRB $5.84
- VNRX $0.52
- Average True Range (ATR)
- NTRB 0.47
- VNRX 0.04
- MACD
- NTRB 0.17
- VNRX 0.00
- Stochastic Oscillator
- NTRB 69.14
- VNRX 78.64
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.